New Delhi, May 26 -- The allotment of Q-Line Biotech IPO, which opened for subscription on 21 May and closed on 25 May, is all set to be finalised on Tuesday, 26 May. The shares of Q-Line Biotech IPO will make their debut on NSE SME on 29 May.

Q-Line Biotech is engaged in the development, manufacturing, and marketing of reagents, including kits, point-of-care (POC) devices, and consumables, along with the manufacturing and distribution of diagnostic equipment catering to healthcare diagnostic requirements.

Its major manufacturing segments comprise indigenous production of reagents across haematology, clinical chemistry, immunodiagnostics, molecular diagnostics, and other categories such as POC devices and rapid tests, as well as the man...